Empagliflozin as treatment in glycogen storage disease type IB patients

Empagliflozin as treatment in glycogen storage disease type IB patients

Background: Glycogen Storage Disease Ib (GSD Ib) is a disease that associates both neutropenia and neutrophil dysfunction, thereby causing recurrent infections and inflammatory bowel disease (IBD). As of now, the standard treatment of these complications has been the administration of granulocyte-st...

Full description

Saved in:
Bibliographic Details
Main Authors: María Arbelo Rodríguez, Elena Márquez Mesa, Cristina Lorenzo González, Marina Gutiérrez Vilar, Loredana Arhip, Mónica Ruiz Pons, José Pablo Suárez Llanos
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Glycogen storage disease type Ib
Empagliflozin
Neutropenia
Neutrophil dysfunction
SGLT2 inhibitors
1,5-andhydroglucitol
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426925000412
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2214426925000412

Similar Items